A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study
- Aydogdu, Ismet
- Ozet, Gulsum
- Sari, Ismail
- Altuntas, Fevzi
- Karakus, Volkan
- Karakus, Abdullah
- Namdaroglu, Sinem
- Salim, Ozan
- Sincan, Gulden
- Yildirim, Rahsan
- Ozarslan, Ibrahim
- Cetin, Guven
- Alacacioglu, Inci
- KAYNAR, Leylagül
- Kaya, Ali Hakan
- KİKİ, İlhami
- ERKURT, MEHMET ALİ
- Yilmaz, Mehmet
- Tekgunduz, Emre
- KUKU, İRFAN
- Kaya, Emin
- Okan, Vahap
- Yildizhan, Esra
- Ozgur, Gokhan
- Ozcebe, Osman Ilhami
- Payzin, Bahriye
- Akpinar, Seval
- Demirkan, Fatih
DOIAbstract
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microangiopathic hemolytic anemia and thrombocytopenia (MAHAT) associated with multiorgan dysfunction as a result of microvascular thrombosis and tissue ischemia. The differentiation of the etiology is of utmost importance as the pathophysiological basis will dictate the choice of appropriate treatment
Add to ORKG